Polymerase Beta Variants and Cancer. Abstract: DNA polymerase beta functions in base excision repair (BER) which is important for the repair of endogenous DNA damage and damage caused by agents such as ionizing radiation. The broad long-term objective of the proposed research is to understand how aberrant BER is linked to carcinogenesis and the treatment of cancer with agents including ionizing radiation. The application consists of three specific aims.
The first aim i s to test the hypothesis that a cancer-associated variant of Pol beta induces tumorigenesis in mice.
The second aim i s to test the hypothesis that a germline variant of Pol beta is linked to cancer. For these aims we will characterize spontaneous and induced tumorigenesis and mutagenesis. We have recently identified colon tumor variants of Pol beta and the third aim is to test the hypothesis that these variants are linked to cancer. We will employ the focus formation and anchorage independent growth assays to characterize cellular transformation. Genomic instability will be assessed using the cII and chromosomal aberration assays. The significance of these studies lies in understanding the role of BER as a tumor suppressor mechanism.

Public Health Relevance

The goal of this application is to determine how variants of the DNA polymerase beta gene found in people and their tumors are linked to cancer. This is important because it has the potential to provide insights into how cancer is initiated and progresses and how it becomes resistant to various cancer therapies.

National Institute of Health (NIH)
National Institute of Environmental Health Sciences (NIEHS)
Research Project (R01)
Project #
Application #
Study Section
Radiation Therapeutics and Biology Study Section (RTB)
Program Officer
Reinlib, Leslie J
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Yale University
Schools of Medicine
New Haven
United States
Zip Code
Ray, Sreerupa; Breuer, Gregory; DeVeaux, Michelle et al. (2018) DNA polymerase beta participates in DNA End-joining. Nucleic Acids Res 46:242-255
Meas, Rithy; Burak, Matthew J; Sweasy, Joann B (2017) DNA repair and systemic lupus erythematosus. DNA Repair (Amst) 56:174-182
Nemec, Antonia A; Abriola, Laura; Merkel, Jane S et al. (2017) DNA Polymerase Beta Germline Variant Confers Cellular Response to Cisplatin Therapy. Mol Cancer Res 15:269-280
Nemec, Antonia A; Bush, Korie B; Towle-Weicksel, Jamie B et al. (2016) Estrogen Drives Cellular Transformation and Mutagenesis in Cells Expressing the Breast Cancer-Associated R438W DNA Polymerase Lambda Protein. Mol Cancer Res 14:1068-1077
Lokanga, Rachel Adihe; Senejani, Alireza Ghodsi; Sweasy, Joann Balazs et al. (2015) Heterozygosity for a hypomorphic Pol? mutation reduces the expansion frequency in a mouse model of the Fragile X-related disorders. PLoS Genet 11:e1005181
Kidane, Dawit; Chae, Wook Jin; Czochor, Jennifer et al. (2014) Interplay between DNA repair and inflammation, and the link to cancer. Crit Rev Biochem Mol Biol 49:116-39
Senejani, Alireza G; Liu, Yanfeng; Kidane, Dawit et al. (2014) Mutation of POLB causes lupus in mice. Cell Rep 6:1-8
Nemec, Antonia A; Murphy, Drew L; Donigan, Katherine A et al. (2014) The S229L colon tumor-associated variant of DNA polymerase ? induces cellular transformation as a result of decreased polymerization efficiency. J Biol Chem 289:13708-16
Ray, Sreerupa; Menezes, Miriam Rose; Senejani, Alireza et al. (2013) Cellular roles of DNA polymerase beta. Yale J Biol Med 86:463-9
Senejani, Alireza G; Dalal, Shibani; Liu, Yanfeng et al. (2012) Y265C DNA polymerase beta knockin mice survive past birth and accumulate base excision repair intermediate substrates. Proc Natl Acad Sci U S A 109:6632-7

Showing the most recent 10 out of 11 publications